Delcath Systems Inc share price logo

Delcath Systems Inc Share Price

NASDAQ: DCTH

Small Cap

$9.07

-0.01

(-0.06%)

as on

Delcath Systems Inc Stock Performance

as on March 7, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $8.90
    $9.12
    downward going graph

    1.87%

    Downside

    0.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.12
    $18.23
    downward going graph

    10.47%

    Downside

    100.99%

    Upside

    downward going graph

Delcath Systems Inc share price movements today

Previous Close
$9.08
Open
$8.90
Volume
433.8K
Day's Low - High
$8.90 - $9.12
52 Week Low - High
$8.12 - $18.23

Delcath Systems Inc Historical Returns

1 Month Return
-3.09 %
3 Month Return
-7.16 %
1 Year Return
-31.32 %
3 Year Return
+ 91.16 %
5 Year Return
-49.3 %

Delcath Systems Inc Stock Fundamentals & Key Indicators

Check Delcath Systems Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$325.9M

EPS (TTM)

-0.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.67%

PE Ratio (TTM)

131.86

Industry PE ratio

0

PEG Ratio

1.5966

EBITDA

898.0K

Revenue (TTM)

85.2M

Profit Margin

3.17%

Return On Equity TTM

3.00%

Delcath Systems Inc Stock Valuation

Track how Delcath Systems Inc P/E has moved over time to understand its valuation trends.

Delcath Systems Inc in the last 5 years

  • Overview

  • Trends

Lowest (-28.39x)

March 31, 2025

Industry (0.00x)

March 6, 2026

Today (131.86x)

March 6, 2026

Highest (142.02x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 131.86x

Delcath Systems Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Delcath Systems Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Delcath Systems Inc image
Delcath Systems Inc
BUY$325.9M-49.3%131.863.17%
Boston Scientific Corp. image
Boston Scientific Corp.
BUY$107.2B84.6%37.2214.44%
Stryker Corporation image
Stryker Corporation
BUY$146.1B54.36%45.4612.92%
Medtronic Plc image
Medtronic Plc
BUY$122.7B-21.35%26.713.00%
Abbott Laboratories image
Abbott Laboratories
BUY$196.5B-5.3%30.414.72%
See all

Stock Returns calculator for Delcath Systems Inc Stock including INR - Dollar returns

The Delcath Systems Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 10Y

Delcath Systems Inc investment value today

Current value as on today

₹73,973

Returns

₹26,027

(-26.03%)

Returns from Delcath Systems Inc Stock

₹31,392 (-31.39%)

Dollar Returns*

₹5,365 (+5.36%)

Analyst Recommendation on Delcath Systems Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Delcath Systems Inc. Average target price of $21.33

Delcath Systems Inc Share Price Target

Get share price movements and forecasts by analysts on Delcath Systems Inc.

What analysts predicted

57.48%UPSIDE

Target Price

$21.33

Current Price

$9.07

Analyzed by

11 Analysts

Target

$21.33

Delcath Systems Inc target price $21.33, a slight upside of 57.48% compared to current price of $9.07. According to 11 analysts rating.

Delcath Systems Inc Stock’s Investor Sentiment and Interest

Search interest for Delcath Systems Inc Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

Delcath Systems Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
3
7
11
15
19
24
20
20
Gross Profit
0
0
2
6
9
12
16
20
17
17
Operating Income
-10
-11
-10
-3
-1
3
0
2
0
-2
EBITDA
-19
-11
-10
-3
-1
10
0
2
0
-1
Interest Expense
0
0
0
0
0
-
-
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-20
-11
-11
-13
1
-3
1
3
0
-1
Income Tax Expense
0
-1
0
-
-
-
0
0
0
0
Net Income
-20
-11
-11
-13
1
-3
1
2
0
-1
Net Profit Margin
-4686.64%
-2066.05%
-353.97%
-176.94%
16.64%
-22.50%
5.40%
11.16%
4.04%
-9.15%

Delcath Systems Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
2
3
1
1
3
2
2
37
85
Gross Profit
1
2
2
0
1
2
2
1
31
73
Operating Income
-16
-18
-27
-19
-21
-24
-33
-38
-12
0
EBITDA
-16
-23
-10
-3
-23
-24
-33
-37
-12
3
Interest Expense
14
21
7
4
0
1
2
1
0
-
Depreciation
-
0
0
1
0
0
0
0
0
0
Income Before Tax
-17
-45
-19
-8
-24
-25
-36
-47
-26
3
Income Tax Expense
14
21
15
4
0
1
2
0
-
0
Net Income
-17
-45
-19
-8
-24
-25
-36
-47
-26
2
Net Profit Margin
-902.16%
-1661.77%
-564.19%
-561.96%
-1467.56%
-721.49%
-1342.70%
-2308.86%
-70.92%
3.17%

Delcath Systems Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-11
-11
-13
1
-3
1
2
0
-1
Operating Cash Flow
-8
-9
-4
-3
-1
2
7
4
8
Investing Cash Flow
-19
4
10
0
-15
-25
0
0
0
Financing Cash Flow
0
4
-2
-2
40
3
14
3
-5
Change in Cash
-27
0
2
-6
24
-19
21
7
1

Delcath Systems Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-45
-19
-8
-24
-25
-36
-47
-26
2
Operating Cash Flow
-15
-14
-23
-22
-22
-24
-31
-18
22
Investing Cash Flow
0
0
0
0
0
0
-19
0
-26
Financing Cash Flow
15
13
30
42
20
10
51
39
15
Change in Cash
0
-1
6
18
-1
-15
0
19
11

Global Institutional Holdings in Delcath Systems Inc

Funds
Holdings
Citadel Advisors Llc
1.29%
Private Wealth Advisors, LLC
0.84%
Qube Research & Technologies
0.8%
Deerfield Management Co
2.32%
Northern Trust Corp
0.73%
See all

Insights on Delcath Systems Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, DCTH has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 20.56M → 20.72M (in $), with an average increase of 0.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, DCTH stock has moved up by 91.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 16.8% return, outperforming this stock by 48.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 2.69M → -1.89M (in $), with an average decrease of 198.8% per quarter

About Delcath Systems Inc

delcath systems, inc. (nasdaq- dcth) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. our proprietary product---melphalan hydrochloride for injection for use with the delcath hepatic delivery system (melphalan/hds)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. delcath is in late-stage clinical development in the united states with initial commercial activities in europe, where the melphalan/hds is marketed as a ce marked device under the trade name delcath hepatic chemosat® delivery system for melphalan (chemosat). our commercial strategy for chemosat is to steadily grow clinical adoption in major european markets and utilize physician experience to support appeals for reimbursement. since launch over 250 chemosat treatments have been performed at over 20 leading european cancer centers. in 2016, we launched our focus pivotal study in hepatic dominant ocular
OrganisationDelcath Systems Inc
Headquarters566 Queensbury Avenue, Queensbury, NY, United States, 12804
IndustryMedical Specialties
CEOMr. Gerard J. Michel MBA, MS
E-voting on sharesClick here to vote

Key Management of Delcath Systems Inc

Name

Title

Dr. Martha S. Rook Ph.D.

Chief Operating Officer

Dr. Vojislav Vukovic M.D., M.Sc., Ph.D.

Chief Medical Officer

Ms. Sandra Pennell CPA

Chief Financial Officer

Mr. David Hoffman J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Dr. Johnny John M.D.

Senior Vice President of Clinical Operations & Medical Affairs

Dr. Michael Brunner M.D.

Senior Vice President of Interventional Oncology

Mr. Gerard J. Michel MBA, MS

CEO & Director

FAQs

What is Delcath Systems Inc share price today?

Delcath Systems Inc share price today is $9.07 as on at the close of the market. Delcath Systems Inc share today touched a day high of $9.12 and a low of $8.9.

What is the 52 week high and 52 week low for Delcath Systems Inc share?

Delcath Systems Inc share touched a 52 week high of $18.23 on and a 52 week low of $8.12 on . Delcath Systems Inc stock price today i.e. is closed at $9.07,which is 50.25% down from its 52 week high and 11.70% up from its 52 week low.

What is Delcath Systems Inc's market capitalisation today?

Delcath Systems Inc market capitalisation is $0.00T as on .

How to invest in Delcath Systems Inc Stock (DCTH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Delcath Systems Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Delcath Systems Inc Shares that will get you 0.1654 shares as per Delcath Systems Inc share price of $9.07 per share as on March 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Delcath Systems Inc Stock (DCTH) from India?

Indian investors can start investing in Delcath Systems Inc (DCTH) shares with as little as ₹91.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.08 in Delcath Systems Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Delcath Systems Inc share’s latest price of $9.07 as on March 7, 2026 at 2:29 am IST, you will get 1.1025 shares of Delcath Systems Inc. Learn more about fractional shares .

What are the returns that Delcath Systems Inc has given to Indian investors in the last 5 years?

Delcath Systems Inc stock has given -49.3% share price returns and 25.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?